These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 24052234)

  • 1. Efficient growth inhibition of EGFR over-expressing tumor cells by an anti-EGFR nanobody.
    Omidfar K; Amjad Zanjani FS; Hagh AG; Azizi MD; Rasouli SJ; Kashanian S
    Mol Biol Rep; 2013 Dec; 40(12):6737-45. PubMed ID: 24052234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient inhibition of EGFR signaling and of tumour growth by antagonistic anti-EFGR Nanobodies.
    Roovers RC; Laeremans T; Huang L; De Taeye S; Verkleij AJ; Revets H; de Haard HJ; van Bergen en Henegouwen PM
    Cancer Immunol Immunother; 2007 Mar; 56(3):303-317. PubMed ID: 16738850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular and functional insight into anti-EGFR nanobody: Theranostic implications for malignancies.
    Tripathy RK; Pande AH
    Life Sci; 2024 May; 345():122593. PubMed ID: 38554946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enzymatic ligation of an antibody and arginine 9 peptide for efficient and cell-specific siRNA delivery.
    Ando Y; Nakazawa H; Miura D; Otake M; Umetsu M
    Sci Rep; 2021 Nov; 11(1):21882. PubMed ID: 34750461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of the single cell gel electrophoresis (comet assay) for comparing apoptotic effect of conventional antibodies versus nanobodies.
    Shaker GH; Melake NA
    Saudi Pharm J; 2012 Jul; 20(3):221-7. PubMed ID: 23960797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody-nanoparticle conjugates to enhance the sensitivity of ELISA-based detection methods.
    Billingsley MM; Riley RS; Day ES
    PLoS One; 2017; 12(5):e0177592. PubMed ID: 28494030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanobody-based immunosensing methods for safeguarding public health.
    Zhang J; Sun H; Pei W; Jiang H; Chen J
    J Biomed Res; 2021 Jul; 35(4):318-326. PubMed ID: 34421007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A robust pipeline for rapid production of versatile nanobody repertoires.
    Fridy PC; Li Y; Keegan S; Thompson MK; Nudelman I; Scheid JF; Oeffinger M; Nussenzweig MC; Fenyö D; Chait BT; Rout MP
    Nat Methods; 2014 Dec; 11(12):1253-60. PubMed ID: 25362362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted Nanobody-Based Molecular Tracers for Nuclear Imaging and Image-Guided Surgery.
    Debie P; Devoogdt N; Hernot S
    Antibodies (Basel); 2019 Jan; 8(1):. PubMed ID: 31544818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naturally occurring antibodies devoid of light chains.
    Hamers-Casterman C; Atarhouch T; Muyldermans S; Robinson G; Hamers C; Songa EB; Bendahman N; Hamers R
    Nature; 1993 Jun; 363(6428):446-8. PubMed ID: 8502296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lateral Flow Assay: A Summary of Recent Progress for Improving Assay Performance.
    Omidfar K; Riahi F; Kashanian S
    Biosensors (Basel); 2023 Aug; 13(9):. PubMed ID: 37754072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single Domain Antibody application in bacterial infection diagnosis and neutralization.
    Qin Q; Liu H; He W; Guo Y; Zhang J; She J; Zheng F; Zhang S; Muyldermans S; Wen Y
    Front Immunol; 2022; 13():1014377. PubMed ID: 36248787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of camelid monoclonal nanobody against SLC39A6 zinc transporter protein.
    Ghaderi H; Noormohammadi Z; Habibi-Anbouhi M; Kazemi-Lomedasht F; Behdani M
    Iran J Basic Med Sci; 2021 Dec; 24(12):1726-1733. PubMed ID: 35432806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EGFR-Targeted Photodynamic Therapy.
    Ulfo L; Costantini PE; Di Giosia M; Danielli A; Calvaresi M
    Pharmaceutics; 2022 Jan; 14(2):. PubMed ID: 35213974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renoprotective Effect of the Recombinant Anti-IL-6R Fusion Proteins by Inhibiting JAK2/STAT3 Signaling Pathway in Diabetic Nephropathy.
    Zhang N; Zheng Q; Wang Y; Lin J; Wang H; Liu R; Yan M; Chen X; Yang J; Chen X
    Front Pharmacol; 2021; 12():681424. PubMed ID: 34054555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanobody: A Small Antibody with Big Implications for Tumor Therapeutic Strategy.
    Sun S; Ding Z; Yang X; Zhao X; Zhao M; Gao L; Chen Q; Xie S; Liu A; Yin S; Xu Z; Lu X
    Int J Nanomedicine; 2021; 16():2337-2356. PubMed ID: 33790553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanobody: a promising toolkit for molecular imaging and disease therapy.
    Bao G; Tang M; Zhao J; Zhu X
    EJNMMI Res; 2021 Jan; 11(1):6. PubMed ID: 33464410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanobodies in cancer.
    Verhaar ER; Woodham AW; Ploegh HL
    Semin Immunol; 2021 Feb; 52():101425. PubMed ID: 33272897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanobodies and Nanobody-Based Human Heavy Chain Antibodies As Antitumor Therapeutics.
    Bannas P; Hambach J; Koch-Nolte F
    Front Immunol; 2017; 8():1603. PubMed ID: 29213270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanobodies as Versatile Tools to Understand, Diagnose, Visualize and Treat Cancer.
    Van Audenhove I; Gettemans J
    EBioMedicine; 2016 Jun; 8():40-48. PubMed ID: 27428417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.